The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) recently awarded the 2019 Heine H. Hansen Award to Francoise Mornex, MD, PhD. The award was presented at the 2019 European Lung Cancer Congress.
Francoise Mornex, MD, PhD
Dr. Mornex is Professor of Oncology at the Universite Claude Bernard in Lyon, France, and practices radiation and medical oncology at the Hospices Civils de Lyon. Her specialty is combined chemoradiation strategies in lung cancer, including multimodality treatment, novel chemoradiation regimens, and innovative radiotherapy techniques. She is passionate about teaching and tutoring young oncologists on research and clinical practice in Europe and Asia, and about improving connections between lung specialists, with the help of ESMO and the IASLC.
Acknowledging the contributions of others to her career, Dr. Mornex gave “a special mention to all women in oncology. They deserve a strategic place in our field and many of them have impressed and influenced me.”
Solange Peters, MD, PhD
Solange Peters, MD, PhD, ESMO President-Elect, said: “I am very pleased to see Professor Mornex’s extensive experience in the study of multimodal therapy for lung cancer patients acknowledged with the Heine H. Hansen Award. Needless to say, as Chair of the ESMO Women for Oncology Committee, it gives me great pride to see this prestigious award given for the first time to a woman.”
The Heine H. Hansen Award honors the lifetime contribution of Prof. Hansen to lung cancer research and education and is awarded to an investigator who has made a special contribution to this field. The Heine H. Hansen Award is presented annually by representatives of ESMO and IASLC at the European Lung Cancer Congress. ■
